Berruti A - Search Results

1

Combination chemotherapy in advanced adrenocortical carcinoma.

Fassnacht M, Terzolo M, Allolio B, Baudin E, Haak H, Berruti A, Welin S, Schade-Brittinger C, Lacroix A, Jarzab B, Sorbye H, Torpy DJ, Stepan V, Schteingart DE, Arlt W, Kroiss M, Leboulleux S, Sperone P, Sundin A, Hermsen I, Hahner S, Willenberg HS, Tabarin A, Quinkler M, de la Fouchardière C, Schlumberger M, Mantero F, Weismann D, Beuschlein F, Gelderblom H, Wilmink H, Sender M, Edgerly M, Kenn W, Fojo T, Müller HH, Skogseid B; FIRM-ACT Study Group. Fassnacht M, et al. Among authors: berruti a. N Engl J Med. 2012 Jun 7;366(23):2189-97. doi: 10.1056/NEJMoa1200966. Epub 2012 May 2. N Engl J Med. 2012. PMID: 22551107 Free article. Clinical Trial.

2

Favorable response of metastatic adrenocortical carcinoma to etoposide, adriamycin and cisplatin (EAP) chemotherapy. Report of two cases.

Berruti A, Terzolo M, Paccotti P, Veglio F, Pia A, Dogliotti L, Angeli A. Berruti A, et al. Tumori. 1992 Oct 31;78(5):345-8. doi: 10.1177/030089169207800512. Tumori. 1992. PMID: 1494808

3

Feasibility of the association of mitotane with etoposide, adriamycin and cisplatin combination chemotherapy in advanced adrenocortical cancer patients. Report on 7 cases.

Pia A, Berruti A, Terzolo M, Paccotti P, Letizia C, Dogliotti L, Angeli A. Pia A, et al. Among authors: berruti a. Ann Oncol. 1995 May;6(5):509-10. doi: 10.1093/oxfordjournals.annonc.a059224. Ann Oncol. 1995. PMID: 7669716 Free article. Clinical Trial. No abstract available.

4

Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.

Berruti A, Terzolo M, Pia A, Angeli A, Dogliotti L. Berruti A, et al. Cancer. 1998 Nov 15;83(10):2194-200. Cancer. 1998. PMID: 9827725 Clinical Trial.

5

Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial.

Berruti A, Terzolo M, Sperone P, Pia A, Della Casa S, Gross DJ, Carnaghi C, Casali P, Porpiglia F, Mantero F, Reimondo G, Angeli A, Dogliotti L. Berruti A, et al. Endocr Relat Cancer. 2005 Sep;12(3):657-66. doi: 10.1677/erc.1.01025. Endocr Relat Cancer. 2005. PMID: 16172198 Clinical Trial.

6

Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane.

Sperone P, Berruti A, Gorzegno G, Paccotti P, Terzolo M, Porpiglia F, Angeli A, Dogliotti L. Sperone P, et al. Among authors: berruti a. J Endocrinol Invest. 2006 Jun;29(6):560-2. doi: 10.1007/BF03344148. J Endocrinol Invest. 2006. PMID: 16840836

7

Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: Diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas.

Volante M, Sperone P, Bollito E, Frangipane E, Rosas R, Daffara F, Terzolo M, Berruti A, Papotti M. Volante M, et al. Among authors: berruti a. Mod Pathol. 2006 Dec;19(12):1563-9. doi: 10.1038/modpathol.3800683. Epub 2006 Sep 15. Mod Pathol. 2006. PMID: 16980949 Free article.

8

Adjuvant mitotane treatment for adrenocortical carcinoma.

Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, Rossetto R, Buci L, Sperone P, Grossrubatscher E, Reimondo G, Bollito E, Papotti M, Saeger W, Hahner S, Koschker AC, Arvat E, Ambrosi B, Loli P, Lombardi G, Mannelli M, Bruzzi P, Mantero F, Allolio B, Dogliotti L, Berruti A. Terzolo M, et al. Among authors: berruti a. N Engl J Med. 2007 Jun 7;356(23):2372-80. doi: 10.1056/NEJMoa063360. N Engl J Med. 2007. PMID: 17554118 Free article.

9

Adjunctive treatment of adrenocortical carcinoma.

Terzolo M, Berruti A. Terzolo M, et al. Among authors: berruti a. Curr Opin Endocrinol Diabetes Obes. 2008 Jun;15(3):221-6. doi: 10.1097/MED.0b013e3282fdf4c0. Curr Opin Endocrinol Diabetes Obes. 2008. PMID: 18438168 Review.

10

Emerging drugs for adrenocortical carcinoma.

Berruti A, Ferrero A, Sperone P, Daffara F, Reimondo G, Papotti M, Dogliotti L, Angeli A, Terzolo M. Berruti A, et al. Expert Opin Emerg Drugs. 2008 Sep;13(3):497-509. doi: 10.1517/14728214.13.3.497. Expert Opin Emerg Drugs. 2008. PMID: 18764725 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

518 results

Search Page